Calretinin Antibody (6A9) [DyLight 488]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-05530G
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human, Mouse, Rat, Porcine, Bovine, Equine
Applications
Immunocytochemistry/ Immunofluorescence, Immunohistochemistry, Western Blot
Label
DyLight 488 (Excitation = 493 nm, Emission = 518 nm)
Antibody Source
Monoclonal Mouse IgA Clone # 6A9
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Full-length recombinant human Calretinin expressed in and purified from E. coli.
Clonality
Monoclonal
Host
Mouse
Isotype
IgA
Applications for Calretinin Antibody (6A9) [DyLight 488]
Application
Recommended Usage
Immunocytochemistry/ Immunofluorescence
Optimal dilutions of this antibody should be experimentally determined.
Immunohistochemistry
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Calretinin
Alternate Names
CAB29, CAL2, CALB2
Gene Symbol
CALB2
Additional Calretinin Products
Product Documents for Calretinin Antibody (6A9) [DyLight 488]
Product Specific Notices for Calretinin Antibody (6A9) [DyLight 488]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...